Skip to content

Remote Mindfulness Breathing Training for Patients Undergoing Chemotherapy

Effects of Remote Mindfulness Breathing Training on Symptom Distress, Fatigue and Psychological Well-Being in Patients Undergoing Chemotherapy

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07806760
Enrollment
80
Registered
2026-09-08
Start date
2026-10-01
Completion date
2027-12-31
Last updated
2026-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Mindfulness, Breathing Exercise, Cancer-Related Fatigue, Symptom Distress, Anxiety, Depression, Mobile Health, Chemotherapy

Brief summary

This randomized controlled trial will evaluate the effects of a mobile-delivered remote mindfulness breathing training program on symptom distress, fatigue, anxiety, and depression in adults with cancer who are receiving chemotherapy. A total of 80 participants will be randomly assigned in a 1:1 ratio to either an intervention group or a control group. The intervention group will complete 5 to 10 minutes of guided mindfulness breathing practice each day for 3 weeks using a mobile-accessible video. The control group will receive usual care and one approximately 5-minute mindfulness breathing instruction session. Outcomes will be assessed at baseline and at the end of the 3-week intervention.

Detailed description

This study is a prospective, two-arm, assessor-blinded randomized controlled trial involving adults with any type of cancer who are receiving chemotherapy in inpatient units or at the Tri-Service General Hospital breast surgery outpatient clinic. After providing written informed consent and completing the baseline assessment, eligible participants will be randomly allocated by computer in a 1:1 ratio to the intervention group or the control group. The intervention group will receive a mobile-delivered remote mindfulness breathing training program and will be instructed to practice with a guided video for approximately 5 to 10 minutes daily for 3 weeks. The control group will receive usual care and one approximately 5-minute mindfulness breathing stress-reduction instruction session. Study assessments will be conducted before the intervention and at the end of week 3. Symptom distress will be assessed using the National Comprehensive Cancer Network Distress Thermometer, fatigue using the Brief Fatigue Inventory, anxiety using the Generalized Anxiety Disorder-7, and depression using the Patient Health Questionnaire-9. To reduce measurement bias, the post-intervention assessment will be conducted by a research assistant who is unaware of the participants' group assignments.

Interventions

BEHAVIORALMobile Remote Mindfulness Breathing Training

Participants will use a mobile-accessible guided video to practice mindfulness awareness combined with slow diaphragmatic breathing for approximately 5 to 10 minutes daily for 3 weeks during chemotherapy, in addition to usual care.

BEHAVIORALBrief Mindfulness Breathing Instruction

Participants will receive one approximately 5-minute mindfulness breathing stress-reduction instruction session in addition to usual care.

Sponsors

Tri-Service General Hospital (TSGH)
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Adults aged 20 years or older with full legal capacity. Diagnosed with any type of cancer and currently receiving chemotherapy as an inpatient or at the Tri-Service General Hospital breast surgery outpatient clinic. Able to understand Chinese or Taiwanese and able to read and operate a smartphone or tablet. Willing to participate in the study and accept random assignment. Have access to a personal mobile device capable of accessing the study materials.

Exclusion criteria

Severe psychiatric disorders, such as schizophrenia or bipolar disorder, or neurodegenerative diseases, such as moderate or severe dementia. Clinical deterioration or poor prognosis requiring a change in treatment or transition to palliative or hospice care. Concurrent participation in another psychological intervention study that may affect emotional outcomes. Deemed unsuitable for breathing training or receiving prolonged sedation.

Design outcomes

Primary

MeasureTime frameDescription
Change in Depression Assessed by the Patient Health Questionnaire-9Baseline and Week 3The Patient Health Questionnaire-9 contains 9 items rated from 0 to 3, producing a total score ranging from 0 to 27. Higher scores indicate greater depressive symptom severity.
Change in Distress Level Assessed by the NCCN Distress ThermometerBaseline and Week 3The NCCN Distress Thermometer is a single-item self-report scale ranging from 0 (no distress) to 10 (extreme distress). Higher scores indicate greater distress.
Change in Fatigue Assessed by the Brief Fatigue InventoryBaseline and Week 3The Brief Fatigue Inventory contains 9 items rated from 0 to 10. The global fatigue score is calculated as the mean of the completed items, with higher scores indicating greater fatigue severity and interference.
Change in Anxiety Assessed by the Generalized Anxiety Disorder-7Baseline and Week 3The Generalized Anxiety Disorder-7 contains 7 items rated from 0 to 3, producing a total score ranging from 0 to 21. Higher scores indicate greater anxiety severity.

Countries

Taiwan

Contacts

CONTACTLei-Yu Chen
leiyu841125@gmail.com+886-2-2764-2151
PRINCIPAL_INVESTIGATORLei-Yu Chen

Tri-Service General Hospital (TSGH)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 9, 2026